• Exchange: Berlin
  • Sector: Financials
  • Industry: Real Estate
  • Sub-Industry: Real Estate Owners & Developers

Advanced Oncotherapy PLC

+ Add to Watchlist

R3I:GR

0.040 EUR 0.0000.00%

As of 02:08:40 ET on 08/28/2014.

Snapshot for Advanced Oncotherapy PLC (R3I)

Open: 0.040 Day's Range: 0.040 - 0.040 Volume: 0
Previous Close: 0.040 52wk Range: 0.023 - 0.043 1-Yr Rtn: +42.86%

Stock Chart for R3I

No chart data available.
  • R3I:GR 0.040
  • 1M
  • 1Y
0.040
Interactive R3I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for R3I

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) -0.0050
Est. PEG Ratio -
Market Cap (M EUR) 34.78
Shares Outstanding (M) 869.54
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for R3I

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for R3I

Advanced Oncotherapy PLC plans, arranges financing for, designs, constructs, and manages health care facilities. The Company is building a portfolio of cancer services to capture opportunities in the cancer diagnosis and treatment market.

Michael Jeffrey Sinclair "Mike"ChairmanLord David EvansDeputy Chairman
Sanjeev PandyaCEO/Executive DirectorGraham PugheVP:Finance/Chief Acctg Officer
More Company Profile & Key Executives for R3I

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil